logo
Select company
Select metric
$ 1.91MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
36
Sector
74
Industry
52
History
96
$ 18.18Close
$ 8.11 - $ 22.48 52-Week Range
Ticker Information

Ticker

ETON

Company Name

ETON PHARMACEUTICALS INC

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

ETON PHARMACEUTICALS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ETON - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 2.71M$ -807K$ 1.91M
3/31/2025$ 1.99M$ -2.27M$ -273K
12/31/2024$ 1.22M$ -2.6M$ -1.38M
9/30/2024$ 1.12M$ -6.02M$ -4.9M
6/30/2024$ 1.03M$ -7.08M$ -6.05M
3/31/2024$ 940K$ 542K$ 1.48M
12/31/2023$ 901K$ -1.19M$ -291K
9/30/2023$ 878K$ 2.66M$ 3.54M
6/30/2023$ 846K$ 316K$ 1.16M
3/31/2023$ 1.81M$ -5.71M$ -3.9M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ETON PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDA stands at $ -21.71M.
  • Over the past 5 years, ETON PHARMACEUTICALS INC's average EBITDA has been $ -6.07M.
  • The median EBITDA for ETON PHARMACEUTICALS INC during this period was $ -5.47M
  • ETON PHARMACEUTICALS INC reached its highest EBITDA over the past 5 years at $ 3.54M.
  • The lowest EBITDA recorded by ETON PHARMACEUTICALS INC in the same timeframe $ -26.46M

ETON PHARMACEUTICALS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
AQST : AQUESTIVE THERAPEUTICS INC $ -47.49MDERM : JOURNEY MEDICAL CORP $ -1.19MLXRX : LEXICON PHARMACEUTICALS INC $ -107.44MTKNO : ALPHA TEKNOVA INC $ -14.29MDCTH : DELCATH SYSTEMS INC $ 1.54MXOMA : XOMA ROYALTY CORP $ -2.98MNKTR : NEKTAR THERAPEUTICS $ -94.15MCDXS : CODEXIS INC $ -46.09MAYTU : AYTU BIOPHARMA INC $ -4.04MMASS : 908 DEVICES INC $ -13.4M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ETON PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -22.35M ] + DepAmor [ $ 638K ]
(=) EBITDA [ $ -21.71M ]

ETON - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -26.46M

Minimum

Dec 31, 2020

$ 3.54M

Maximum

Sep 30, 2023

$ -6.07M

Average

$ -5.47M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M